GLUSCAN

This brand name is authorized in Spain, France, Poland, South Africa

Active ingredients

The drug GLUSCAN contains one active pharmaceutical ingredient (API):

1 Fludeoxyglucose ¹⁸F UNII 0Z5B2CJX4D - FLUDEOXYGLUCOSE F-18

Fludeoxyglucose F18 is a glucose analog that concentrates in cells that rely upon glucose as an energy source, or in cells whose dependence on glucose increases under pathophysiological conditions. Fludeoxyglucose F18 is used to assess glucose metabolism. It is a positron emitting radiopharmaceutical that is used for diagnostic purposes in conjunction with positron emission tomography (PET) imaging. Read about Fludeoxyglucose ¹⁸F

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
GLUSCAN Solution for injection	Web Search	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V09IX04	Fludeoxyglucose (18F)	V Various → V09 Diagnostic radiopharmaceuticals → V09I Tumour detection → V09IX Other diagnostic radiopharmaceuticals for tumour detection
Discover more medicines within V09IX04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 81346
Country: FR	Base de données publique des médicaments	Identifier(s): 62664912
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100235817, 100364510
Country: ZA	Health Products Regulatory Authority	Identifier(s): 41/35/0544